Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases

Innorna Co., Ltd. China Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/innorna-announces-fda-clearance-of-ind-for-in026-advancing-mrna-based-therapies-into-chronic-metabolic-diseases-302715622.html